Zaks Tal Zvi

Director, Chief Medical Officer · SEC CIK 1690927
Advertisement

Buy track record

How this insider's open-market purchases have performed
This insider has no open-market purchases in the records we parsed, so there's no buy track record to score. Their full filing history is below.
Advertisement
Open-market buys
$0
0 trades
Open-market sells
$28.73M
157 trades
Net flow
−$28.73M
Net selling
Total filings
199
transactions shown

Full transaction history

All Form 4 activity across every company, newest first
View on SEC EDGAR ↗
Advertisement
MRNA
Option exercise Zaks Tal Zvi · Chief Medical Officer · Option exercise · filed Jul 2, 2021 ΔOwn NEW
+$129.7K
5,000 sh @ $26
MRNA
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Jul 2, 2021 ΔOwn −100%

Zaks Tal Zvi sold $1.19M of MRNA, trimming their stake 100%.

−$1.19M
5,000 sh @ $237
MRNA
Option exercise Zaks Tal Zvi · Chief Medical Officer · Option exercise · filed Jun 25, 2021 ΔOwn NEW
+$129.7K
5,000 sh @ $26
MRNA
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Jun 25, 2021 ΔOwn −100%

Zaks Tal Zvi sold $1.1M of MRNA, trimming their stake 100%.

−$1.1M
5,000 sh @ $220
MRNA
Option exercise Zaks Tal Zvi · Chief Medical Officer · Option exercise · filed Jun 21, 2021 ΔOwn NEW
+$129.7K
5,000 sh @ $26
MRNA
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Jun 21, 2021 ΔOwn −100%

Zaks Tal Zvi sold $1M of MRNA, trimming their stake 100%.

−$1M
5,000 sh @ $200
MRNA
Option exercise Zaks Tal Zvi · Chief Medical Officer · Option exercise · filed Jun 11, 2021 ΔOwn NEW
+$129.7K
5,000 sh @ $26
MRNA
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Jun 11, 2021 ΔOwn −100%

Zaks Tal Zvi sold $1.06M of MRNA, trimming their stake 100%.

−$1.06M
5,000 sh @ $212
MRNA
Option exercise Zaks Tal Zvi · Chief Medical Officer · Option exercise · filed Jun 3, 2021 ΔOwn NEW
+$129.7K
5,000 sh @ $26
MRNA
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Jun 3, 2021 ΔOwn −100%

Zaks Tal Zvi sold $919.5K of MRNA, trimming their stake 100%.

−$919.5K
5,000 sh @ $184
MRNA
Option exercise Zaks Tal Zvi · Chief Medical Officer · Option exercise · filed May 27, 2021 ΔOwn NEW
+$129.7K
5,000 sh @ $26
MRNA
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed May 27, 2021 ΔOwn −100%

Zaks Tal Zvi sold $843.5K of MRNA, trimming their stake 100%.

−$843.5K
5,000 sh @ $169
MRNA
Option exercise Zaks Tal Zvi · Chief Medical Officer · Option exercise · filed May 20, 2021 ΔOwn NEW
+$129.7K
5,000 sh @ $26
MRNA
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed May 20, 2021 ΔOwn −100%

Zaks Tal Zvi sold $778.7K of MRNA, trimming their stake 100%.

−$778.7K
5,000 sh @ $156
MRNA
Option exercise Zaks Tal Zvi · Chief Medical Officer · Option exercise · filed May 13, 2021 ΔOwn NEW
+$129.7K
5,000 sh @ $26
MRNA
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed May 13, 2021 ΔOwn −100%

Zaks Tal Zvi sold $770.6K of MRNA, trimming their stake 100%.

−$770.6K
5,000 sh @ $154
MRNA
Option exercise Zaks Tal Zvi · Chief Medical Officer · Option exercise · filed May 11, 2021 ΔOwn NEW
+$44.8K
3,670 sh @ $12
MRNA
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed May 11, 2021 ΔOwn −16%

Zaks Tal Zvi sold $94K of MRNA, trimming their stake 16%.

−$94K
600 sh @ $157
MRNA
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed May 11, 2021 ΔOwn −32%

Zaks Tal Zvi sold $155.1K of MRNA, trimming their stake 32%.

−$155.1K
985 sh @ $157
MRNA
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed May 11, 2021 ΔOwn −76%

Zaks Tal Zvi sold $251.8K of MRNA, trimming their stake 76%.

−$251.8K
1,585 sh @ $159
MRNA
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed May 11, 2021 ΔOwn −40%

Zaks Tal Zvi sold $31.9K of MRNA, trimming their stake 40%.

−$31.9K
200 sh @ $160
MRNA
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed May 11, 2021 ΔOwn −33%

Zaks Tal Zvi sold $16.2K of MRNA, trimming their stake 33%.

−$16.2K
100 sh @ $162
MRNA
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed May 11, 2021 ΔOwn −100%

Zaks Tal Zvi sold $32.6K of MRNA, trimming their stake 100%.

−$32.6K
200 sh @ $163
MRNA
Option exercise Zaks Tal Zvi · Chief Medical Officer · Option exercise · filed May 4, 2021 ΔOwn NEW
+$61.1K
5,000 sh @ $12
MRNA
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed May 4, 2021 ΔOwn −5.4%

Zaks Tal Zvi sold $49.7K of MRNA, trimming their stake 5%.

−$49.7K
271 sh @ $183

Frequently asked questions

How is Zaks Tal Zvi's win rate calculated?

We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.

Why are some buys not included in the score?

A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.

What do the 1M / 3M / 6M / 12M columns mean?

They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.

Does a high win rate mean I should copy this insider?

No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.

Where does this data come from?

Trades come from Zaks Tal Zvi's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.